
Loading, please wait...

Loading, please wait...

Managing pituitary adenoma requires precise monitoring of postoperative morning cortisol levels. Recent research highlights that these levels serve as robust predictors for secondary adrenal insufficiency (SAI). Specifically, clinicians can use these markers to determine which patients require long-term glucocorticoid replacement. Furthermore, this approach reduces unnecessary testing while ensuring patient safety during the recovery phase.
The study suggests that POD2 cortisol measurements offer superior predictive accuracy compared to POD1. Although POD1 is a common benchmark, the second-day measurement provides a more stable reflection of the hypothalamic-pituitary-adrenal axis. Consequently, identifying patients at risk of SAI becomes more reliable. Researchers found that a POD2 morning cortisol cutoff of 12.3 µg/dL achieved a 100% negative predictive value. Therefore, patients exceeding this threshold may safely avoid long-term steroid therapy.
Besides adrenal function, patients often experience other endocrine deficiencies after pituitary resection. These include hypogonadism, hypothyroidism, and growth hormone deficiency. Additionally, arginine vasopressin deficiency remains a concern. Because persistent hypopituitarism affects nearly one-fourth of patients, consistent follow-up is mandatory. However, POD2 cortisol remains the strongest predictor for the most critical deficiency: secondary adrenal insufficiency.
A level of 12.3 µg/dL acts as the optimal threshold for predicting long-term adrenal sufficiency with high confidence.
POD2 measurements demonstrate higher discriminative performance with an AUC of 0.990, compared to 0.719 for POD1.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.
References
Liu KG et al. Postoperative days 1 and 2 morning cortisol levels as predictors of long-term secondary adrenal insufficiency following pituitary adenoma surgery. J Neurosurg. 2026 Feb 06. doi: 10.3171/2025.9.JNS251261. PMID: 41650448.
Elshimy G et al. Early Morning Cortisol Level as a Predictive Factor for Long-Term Glucocorticoid Replacement After Pituitary Surgery: A Systematic Review and Meta-Analysis. Pituitary. 2023.
Endocrine Society. Clinical Practice Guideline: Management of Pituitary Surgery Outcomes and Adrenal Insufficiency. 2024.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies POD2 morning cortisol (cutoff 12.3 µg/dL) as a superior predictor of long-term secondary adrenal insufficiency post-pituitary surger...
8 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today